TARGETED RELEASE RIFAXIMIN COMPOSITIONS

Provided herein are GI specific rifaximin release compositions which can be formulated for targeted delivery of rifaximin to one or more portions of the GI tract. Methods of treating diseases and disorders with the disclosed compositions are also provided.

Saved in:
Bibliographic Details
Main Authors STEIN, Daniel J, ISRAEL, Robert J, LOWE, Ezra R, COLE, Jacob, ROHRS, Brian R
Format Patent
LanguageEnglish
French
German
Published 03.05.2023
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Provided herein are GI specific rifaximin release compositions which can be formulated for targeted delivery of rifaximin to one or more portions of the GI tract. Methods of treating diseases and disorders with the disclosed compositions are also provided.
Bibliography:Application Number: EP20210739302